Medtronic's diabetes unit MiniMed raises $560 million in US IPO
06/03/2026 24:39
March 5 (Reuters) - MiniMed, the diabetes business of medical device maker Medtronic MDT.N, said on Thursday it has raised $560 million in its U.S. initial public offering. (Reporting by Manya Saini in Bengaluru and Carlos Méndez in Mexico City; Editing by Sumana Nandy and Sahal Muhammed) ((Manya.Saini@thomsonreuters.com; X: manya__saini;))
Recent news on Medtronic
See all newsStreet View: Medtronic moves from 'show me' story to 'trust the setup' story
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway
Medtronic climbs after Q4 results beat estimates